Mem.Ax
MEM.AX operates in the Advanced Medical Equipment & Technology industry, providing specialized medical devices and technologies for healthcare applications.
Business. MEM.AX operates in the Advanced Medical Equipment & Technology industry, providing specialized medical devices and technologies for healthcare applications.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
MEM.AX operates in the Advanced Medical Equipment & Technology industry, providing specialized medical devices and technologies for healthcare applications.
MEM.AX has a market price of 0.005 AUD and a market capitalization of 14,236,168.71 AUD, indicating a small-cap profile. The company's price-to-book ratio is 3.28, and its price-to-tangible-book ratio is also 3.28, suggesting that the market is valuing the company's equity at a premium relative to its book value. The enterprise value to EBITDA ratio is -4.36, and the enterprise value to revenue ratio is 5,253.67, both of which are significantly negative and high, respectively, indicating poor profitability and a high valuation relative to revenue.
The company's profitability metrics are concerning. The return on equity is -1.16, and the return on assets is -0.45, both of which are negative, indicating that the company is not generating returns for its shareholders or effectively utilizing its assets. The debt-to-equity ratio is 1.2, and the current ratio is 0.2, suggesting that the company has a high level of debt relative to equity and limited short-term liquidity to cover its current liabilities.
The company's capital structure is heavily leveraged, with long-term debt amounting to 5,202,410 AUD and total liabilities of 6,870,110 AUD. The company's total equity is 4,341,650 AUD, and the debt-to-equity ratio of 1.2 indicates that the company is financed more by debt than by equity. The company's liquidity position is weak, with a current ratio of 0.2, indicating that it has only 0.2 AUD in current assets for every 1 AUD in current liabilities.
The company's operating performance is poor, with a gross profit of -35,590 AUD, an operating income of -4,458,720 AUD, and a net income of -5,039,080 AUD. The company's operating cash flow is -2,401,330 AUD, and its free cash flow is -5,192,510 AUD, indicating that the company is not generating positive cash flows from its operations. The company's capital expenditure is -819,730 AUD, suggesting that it is not investing in its operations.
The company's risk profile is characterized by medium liquidity risk and low dilution risk. The key flag is that the company has negative net cash after subtracting total debt, indicating a liquidity constraint. The company's financial position is weak, with a high level of debt and negative cash flows, which could pose a risk to its ability to meet its obligations.
The company's recent financial performance and risk profile suggest that it is facing significant challenges. The company's negative profitability metrics, high debt levels, and weak liquidity position indicate that it is not in a strong financial position. The company's ability to generate positive cash flows and improve its profitability will be critical to its long-term viability.
- MEM.AX has a weak financial position with a high debt-to-equity ratio and negative profitability metrics.
- The company's liquidity position is poor, with a current ratio of 0.2 and negative net cash after subtracting total debt.
- The company's valuation metrics, such as the enterprise value to EBITDA and enterprise value to revenue ratios, are significantly negative and high, respectively.
- The company's operating performance is poor, with negative gross profit, operating income, and net income.
- The company's risk profile is characterized by medium liquidity risk and low dilution risk.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- MEM.AX Market data — financials · 2026-05-28